Taken together, these results indicate that A223 tumors do not express PD-L1 in a TGFβ-dependent manner, and the primary target for anti-PD-L1 in both A223 and human HNSCC tumors lies on infiltrating leukocytes rather than the tumor cells themselves. This evidence concerns the gene TGFB1 and neoplasm.